Functional analysis and intracellular localization of p53 modified by SUMO-1

被引:113
作者
Kwek, SSS [1 ]
Derry, J [1 ]
Tyner, AL [1 ]
Shen, ZY [1 ]
Gudkov, AV [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA
关键词
SUMO-1; p53; transactivation; cellular localization;
D O I
10.1038/sj.onc.1204362
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 tumor suppressor is a subject of several posttranslational modifications, including phosphorylation, ubiquitination and acetylation, which regulate p53 function. A new covalent modification of p53 at lysine 386 by SUMO-1 was recently identified. To elucidate the function of sumoylated p53, we compared the properties of wild type p53 and sumoylation-deficient p53 mutant, K386R, No differences were found between wild type p53 and K386R mutant of p53 in transactivation or growth suppression assays. Moreover, overexpression of SUMO-1 has no effect on p53-regulated transcription. Biochemical fractionation showed that sumoylated p53 is localized in the nucleus and is tightly bound to chromatin structures. p53 and SUMO-1 colocalized in PML nuclear bodies in 293 cells and the nucleoli in MCF7 and HT1080 cells. However, sumoylation-deficient p53 mutant showed a similar pattern of intranuclear localization, suggesting that SUMO-1 does not target p53 to subnuclear structures. These data indicate that SUMO-1 modification of p53 at lysine 386 may not be essential for p53's cellular localization, transcriptional activation, or growth regulation.
引用
收藏
页码:2587 / 2599
页数:13
相关论文
共 69 条
[31]   Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1 [J].
Kim, YH ;
Choi, CY ;
Kim, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12350-12355
[32]   Tumor-suppressor p53: Implications for tumor development and prognosis [J].
Kirsch, DG ;
Kastan, MB .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) :3158-3168
[33]  
Kondratov R. V., 1996, Molekulyarnaya Biologiya (Moscow), V30, P613
[34]   Keeping an old friend under control: regulation of p53 stability [J].
Kubbutat, MHG ;
Vousden, KH .
MOLECULAR MEDICINE TODAY, 1998, 4 (06) :250-256
[35]   An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs [J].
Laín, S ;
Midgley, C ;
Sparks, A ;
Lane, EB ;
Lane, DP .
EXPERIMENTAL CELL RESEARCH, 1999, 248 (02) :457-472
[36]   Regulation of p53 in response to DNA damage [J].
Lakin, ND ;
Jackson, SP .
ONCOGENE, 1999, 18 (53) :7644-7655
[37]   The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components [J].
Leppard, KN ;
Everett, RD .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :997-1008
[38]   A new protease required for cell-cycle progression in yeast [J].
Li, SJ ;
Hochstrasser, M .
NATURE, 1999, 398 (6724) :246-251
[39]   Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein [J].
Li, WH ;
Hesabi, B ;
Babbo, A ;
Pacione, C ;
Liu, JM ;
Chen, DJ ;
Nickoloff, JA ;
Shen, ZY .
NUCLEIC ACIDS RESEARCH, 2000, 28 (05) :1145-1153
[40]   Binding and modulation of p53 by p300/CBP coactivators [J].
Lill, NL ;
Grossman, SR ;
Ginsberg, D ;
DeCaprio, J ;
Livingston, DM .
NATURE, 1997, 387 (6635) :823-827